Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 11/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574662 | 1.00 | FOLH1 (0.51) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| SCHEMBL27165479 | 0.83 | FOLH1 (0.46) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| SCHEMBL164121 | 0.79 | FOLH1 (0.56) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| SCHEMBL165084 | 0.79 | FOLH1 (0.56) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| SCHEMBL168589 | 0.79 | FOLH1 (0.56) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| SCHEMBL29894486 | 0.78 | FOLH1 (0.59) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| SCHEMBL29390540 | 0.78 | FOLH1 (0.59) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| Hydrochloric Acid SCHEMBL25283310 | 0.77 | FOLH1 (0.54) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| Hydrochloric Acid SCHEMBL8332033 | 0.77 | FOLH1 (0.54) | FOLH1GSRRNPEPCPB2SLC6A5 | |
| Methane SCHEMBL15135720 | 0.77 | FOLH1 (0.54) | FOLH1GSRRNPEPCPB2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117757023-B | High-salt low-permeability oil reservoir oil displacement agent containing betaine type surfactant and preparation method thereof | 西安石油大油气科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-117757023-A | High-salt low-permeability oil reservoir oil displacement agent containing betaine type surfactant and preparation method thereof | 西安石油大油气科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-10-16 | — | — | US | claimed |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW (IL) | 2011-07-21 | — | — | US | claimed |
| EP-2262763-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2010-12-22 | — | — | EP | claimed |
| WO-2009109973-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2009-09-11 | — | — | WO | claimed |
| CN-117757023-B | High-salt low-permeability oil reservoir oil displacement agent containing betaine type surfactant and preparation method thereof | 西安石油大油气科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-117757023-A | High-salt low-permeability oil reservoir oil displacement agent containing betaine type surfactant and preparation method thereof | 西安石油大油气科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-10457628-B2 | Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image | FUJIFILM CORPORATION (JP) | 2019-10-29 | — | — | US | disclosed |
| CN-105916894-B | Polymerizable compound, polymerizable composition, polymerizable composition, film and projected image, which are shown, uses semi-transparent semi-reflecting lens | 富士胶片株式会社 | 2018-02-13 | — | — | CN | disclosed |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | FUJIFILM CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| CN-105916894-A | Polymerizable compound, polymerizable composition, film and half mirror for displaying projected image | 富士胶片株式会社 | 2016-08-31 | — | — | CN | disclosed |
| US-9428448-B2 | Compounds and methods of treating obesity | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-08-30 | — | — | US | disclosed |
| EP-2601205-A2 | GUANINE NUCLEOTIDE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012017434-A2 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2012-02-09 | — | — | WO | disclosed |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW (IL) | 2011-07-21 | — | — | US | disclosed |
| US-20110086813-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2011-04-14 | — | — | US | disclosed |
| EP-2262763-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2010-12-22 | — | — | EP | disclosed |
| WO-2009116044-A2 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009109973-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10457628-B2 | Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image | PYM1, C5, C1S | FOLH1 4153/4885GSR 4500/4885RNPEP 3854/4885 |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | FABP4, LIPC, GPR119 | FOLH1 1869/4885GSR 724/4885RNPEP 3120/4885 |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | PYM1, C5, C1S | FOLH1 4147/4885GSR 4467/4885RNPEP 3848/4885 |
| US-20110086813-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | REL, RELA, NFKB1 | FOLH1 3948/4885GSR 2244/4885RNPEP 2446/4885 |
| US-20110178151-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | GPR119, FABP4, LIPC | FOLH1 1777/4885GSR 958/4885RNPEP 3404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.